1243163-72-5Relevant articles and documents
INDAZOLES AS LRRK2 INHIBITORS
-
Page/Page column 85, (2020/10/09)
The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
Page/Page column 61, (2012/11/08)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.